Patents by Inventor Jennifer Davidson HAMILTON

Jennifer Davidson HAMILTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating or preventing asthma by administering an IL-4R antagonist
    Patent number: 11845800
    Abstract: The present invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: December 19, 2023
    Assignees: SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS, INC.
    Inventors: Marius Ardeleanu, Namita A. Gandhi, Neil Graham, Stephane C. Kirkesseli, Sudeep Kundu, Ross E. Rocklin, Allen Radin, Steven P. Weinstein, Jennifer Davidson Hamilton, Jeffrey Ming
  • Transcriptome Analysis For Treating Inflammation
    Publication number: 20230340601
    Abstract: The present disclosure provides methods of identifying a disease or condition suitable for treatment with dupilumab. The present disclosure also provides methods of identifying a subject having a disease or condition suitable for treatment with dupilumab. The present disclosure also provides methods of carrying out a clinical trial for dupilumab treatment of a disease or condition.
    Type: Application
    Filed: April 25, 2023
    Publication date: October 26, 2023
    Inventors: Wei Keat Lim, Kaitlyn Gayvert, Sivan Harel, Jennifer Davidson Hamilton, Sara Hamon, Matthew F. Wipperman
  • METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20230058395
    Abstract: The present invention provides methods for treating atopic dermatitis (AD). Also provided are methods for improving one or more AD-associated parameter(s), and methods for decreasing the level of at least one AD-associated biomarker in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
    Type: Application
    Filed: September 23, 2022
    Publication date: February 23, 2023
    Inventors: Marius ARDELEANU, Neil GRAHAM, Jennifer Davidson HAMILTON, Stephane C. KIRKESSELI, Sudeep KUNDU, Jeffrey MING, Allen RADIN, Ross E. ROCKLIN, Steven Paul WEINSTEIN
  • METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20180016343
    Abstract: The present invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Application
    Filed: June 20, 2017
    Publication date: January 18, 2018
    Inventors: Marius Ardeleanu, Namita A. Gandhi, Neil Graham, Stephane C. Kirkesseli, Sudeep Kundu, Ross E. Rocklin, Allen Radin, Steven P. Weinstein, Jennifer Davidson Hamilton, Jeffrey Ming
  • Methods for Treating Atopic Dermatitis by Administering an IL-4R Antagonist
    Publication number: 20170333557
    Abstract: The present invention provides methods for treating atopic dermatitis (AD). Also provided are methods for improving one or more AD-associated parameter(s), and methods for decreasing the level of at least one AD-associated biomarker in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
    Type: Application
    Filed: May 31, 2017
    Publication date: November 23, 2017
    Inventors: Marius ARDELEANU, Neil GRAHAM, Jennifer Davidson HAMILTON, Stephane C. KIRKESSELI, Sudeep KUNDU, Jeffrey MING, Allen RADIN, Ross E. ROCKLIN, Steven Paul WEINSTEIN
  • Methods for treating or preventing asthma by administering an IL-4R antagonist
    Patent number: 9574004
    Abstract: The present invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: February 21, 2017
    Assignees: Sanofi Biotechnology, Regeneron Pharmaceuticals, Inc.
    Inventors: Marius Ardeleanu, Namita A. Gandhi, Neil Graham, Stephanie C. Kirkesseli, Sudeep Kundu, Ross E. Rocklin, Allen Radin, Steven P. Weinstein, Jennifer Davidson Hamilton, Jeffrey Ming
  • METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20140072583
    Abstract: The present invention provides methods for treating atopic dermatitis (AD). Also provided are methods for improving one or more AD-associated parameter(s), and methods for decreasing the level of at least one AD-associated biomarker in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
    Type: Application
    Filed: September 4, 2013
    Publication date: March 13, 2014
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Marius ARDELEANU, Neil GRAHAM, Jennifer Davidson HAMILTON, Stephane C. KIRKESSELI, Sudeep KUNDU, Jeffrey MING, Allen RADIN, Ross E. ROCKLIN, Steven Paul WEINSTEIN
  • METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20140056920
    Abstract: The present invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Application
    Filed: August 20, 2013
    Publication date: February 27, 2014
    Applicants: REGENERON PHARMACEUTICALS, INC., SANOFI
    Inventors: Marius ARDELEANU, Namita A. GANDHI, Neil GRAHAM, Stephane C. KIRKESSELI, Sudeep KUNDU, Ross E. ROCKLIN, Allen RADIN, Steven P. WEINSTEIN, Jennifer Davidson HAMILTON, Jeffrey MING